Interestingly, although AREG level was significantly higher in HCC patients than cirrhotic and control groups, the presence of portal vein thrombosis or metastasis in HCC patients showed significantly lower serum AREG level as compared to non-metastatic patients and those without portal vein thrombosis. This evidence concerns the gene AREG and Portal vein thrombosis.